Search

Your search keyword '"Colantuono, Stefania"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Colantuono, Stefania" Remove constraint Author: "Colantuono, Stefania"
170 results on '"Colantuono, Stefania"'

Search Results

1. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

4. Severe asthma: One disease and multiple definitions

5. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

6. Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?

7. RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists.

10. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

11. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)

13. Immunoglobulin Free Light Chains in Severe Asthma Patient: could they be a new biomarker?

14. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia.

15. Clinical research coordinators: Key components of an efficient clinical trial unit

16. Clinical research coordinators: Key components of an efficient clinical trial unit

17. Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review

18. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity

19. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

21. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

24. Clinical research coordinators: Key components of an efficient clinical trial unit

25. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity

26. Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review

29. Severe asthma: One disease and multiple definitions

31. Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review.

33. β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic

34. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression

35. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy

37. Cryoglobulins: putative effectors of adaptive immune response

38. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy

39. Mutational and immunogenetic landscape of HCV ‐associated B‐cell lymphoproliferative disorders

40. Cryoglobulins: putative effectors of adaptive immune response

41. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression

42. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

43. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy

46. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)

49. Immunobiology of essential mixed cryoglobulinemia

50. Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.

Catalog

Books, media, physical & digital resources